Ke Jie

Ke is originally from China and he received his B.S. degree in Chemistry from College of Science in Northeastern University, Boston. During his undergraduate career, he carried out research at Boston Children’s Hospital/Harvard Medical School, where he was involved in the identification of genes associated with bladder cancer using a CRISPR/cas9 system. Currently, he is a graduate student in the Chemistry and Biochemistry Ph.D. program and joined the Dodani lab in Spring 2019 where he is engineering new genetically encoded reporters for anions. During his free time, Ke enjoys playing guitar and ukulele.